Catalent
CTLT
#1737
Rank
S$14.93 B
Marketcap
S$82.26
Share price
0.00%
Change (1 day)
9.94%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Last known market cap: S$14.93 Billion

On February 19, 2025 Catalent had a market cap of S$14.93 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025S$14.93 B-4.66%
2024S$15.66 B46.11%
2023S$10.71 B-1.29%
2022S$10.85 B-64.95%
2021S$30.98 B36.63%
2020S$22.67 B104.06%
2019S$11.11 B79.14%
2018S$6.20 B-15.03%
2017S$7.29 B49.97%
2016S$4.86 B10.41%
2015S$4.40 B-3.34%
2014S$4.56 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Supernus Pharmaceuticals
SUPN
S$3.39 B-77.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S$0.97 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
S$13.36 B-10.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
S$1.02 B-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA